Conference · Lisbon, Portugal
Antibody Drug Conjugates Conference
Biotechnology
Key numbers
- Editions on record
- 1first in 2018
About Antibody Drug Conjugates Conference
As more Antibody-Drug Conjugates head to market, the next-generation of ADCs looms on the horizon. Next-gen engineering requires designing an optimal antibody, payload, linker and conjugation method while ensuring stability, targeted delivery, and limited off-target effects. The “Next-Generation Antibody-Drug Conjugates” conference explores the engineering finesse required to achieve improved therapeutics while adhering to the underlying biology that research has uncovered, showing the way to more potent and efficacious molecules. Case Studies and data will be shared that exemplify the ongoing efforts to engineer ADCs, move them into the clinic, and fight cancer along with potentially non-oncological indications.
From our listing of this edition. Details may have changed since.
Editions
| Year | Dates | Where | Exhibitors | Visitors |
|---|---|---|---|---|
| 2018 | 12–13 Nov 2018 | Lisbon Congress Centre Lisbon, Portugal | — | — |
Past editions from the bvents archive (2008–2019) and organiser figures where they were published.
Questions
When is Antibody Drug Conjugates Conference?
The next dates haven't been confirmed. The last edition we have on record was 12–13 Nov 2018.
Where is it held?
The last edition we have was at Lisbon Congress Centre, Lisbon, Portugal.